Revised package insert for atazanavir.
Sax
Paul E
PE
D000069446:Atazanavir Sulfate; D004348:Drug Labeling; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006635:Histamine H2 Antagonists / Q000008:administration & dosage; D006801:Humans; D009842:Oligopeptides / Q000009:adverse effects / Q000627:therapeutic use*; D054328:Proton Pump Inhibitors / Q000008:administration & dosage; D011725:Pyridines / Q000009:adverse effects / Q000627:therapeutic use*
D017320:HIV Protease Inhibitors; D006635:Histamine H2 Antagonists; D009842:Oligopeptides; D054328:Proton Pump Inhibitors; D011725:Pyridines; D000069446:Atazanavir Sulfate